Compare TLSA & RSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLSA | RSSS |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.7M | 97.3M |
| IPO Year | 2000 | N/A |
| Metric | TLSA | RSSS |
|---|---|---|
| Price | $1.60 | $2.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 420.3K | 75.7K |
| Earning Date | 05-06-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $49,325,684.00 |
| Revenue This Year | N/A | $4.92 |
| Revenue Next Year | N/A | $7.09 |
| P/E Ratio | ★ N/A | $73.25 |
| Revenue Growth | N/A | ★ 5.83 |
| 52 Week Low | $0.63 | $2.32 |
| 52 Week High | $2.60 | $4.24 |
| Indicator | TLSA | RSSS |
|---|---|---|
| Relative Strength Index (RSI) | 43.87 | 48.60 |
| Support Level | $1.45 | $2.82 |
| Resistance Level | $1.62 | $3.05 |
| Average True Range (ATR) | 0.16 | 0.13 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 46.15 | 47.66 |
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.